Quality of life and functional outcomes with tapentadol prolonged release in chronic musculoskeletal pain: post hoc analysis
| Autor: | Paz Sanz-Ayan, Ravi Karra, Guido Thömmes, Alberto Magni, Hiltrud Liedgens, Carlos Guerrero, Argelia Lara-Solares, Silvia Natoli, Cesar Margarit Ferri |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
tapentadol PR SF-36 oxycodone physical health outcomes Settore MED/06 Quality of life Post-hoc analysis medicine functionality business.industry Chronic pain mental health outcomes General Medicine medicine.disease Tapentadol Low back pain health-related quality of life functional outcomes Knee pain Settore MED/41 Physical therapy medicine.symptom business Oxycodone medicine.drug |
| Popis: | Aims: To investigate quality of life (QOL) and functionality changes in chronic pain during tapentadol prolonged release (PR) treatment. Patients & methods: Post hoc analysis of data from three Phase III trials in patients with osteoarthritis knee pain or low back pain. QOL and functionality changes were assessed by SF-36 scores. Results: All SF-36 subdomain scores improved progressively to week 3 of tapentadol titration and were sustained during 12-week maintenance treatment. Improvements in SF-36 scores were similar between tapentadol dose groups (e.g., 200 to |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|